These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 2290598
21. [Follow-up study of clinical effects of californium-252 neutron intracavitary radiotherapy and external beam radiotherapy in endometrial cancer]. Lei X, Shan JL, Tang C, Zhao KW. Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):733-6. PubMed ID: 18307897 [Abstract] [Full Text] [Related]
22. Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study. Bodner-Adler B, Bodner K, Obermair A, Czerwenka K, Petru E, Leodolter S, Mayerhofer K. Anticancer Res; 2001 Nov; 21(4B):3069-74. PubMed ID: 11712812 [Abstract] [Full Text] [Related]
23. [Results of surgical, combined and complex treatment of patients with uterine cancer]. Barinov VV, Kushlinskiĭ NE, Zhordania KI, Peskova VI, Bokina LI, Rotobel'skaia LE. Vopr Onkol; 1998 Nov; 44(5):533-6. PubMed ID: 9884709 [Abstract] [Full Text] [Related]
24. Incidence and prognosis of endometrial carcinoma by histologic grade and extent. Ng AB, Reagan JW. Obstet Gynecol; 1970 Mar; 35(3):437-43. PubMed ID: 5416706 [No Abstract] [Full Text] [Related]
26. [Radical surgery of endometrial cancer]. Moutiquin JM, Meunier P, Ouimet C. Union Med Can; 1973 Feb; 102(2):361-6. PubMed ID: 4709472 [No Abstract] [Full Text] [Related]
27. [Postoperative irradiation of carcinoma of the corpus uteri using the iridium afterloading technic]. Kucera H, Weghaupt K. Strahlenther Onkol; 1988 Sep; 164(9):501-7. PubMed ID: 3175848 [Abstract] [Full Text] [Related]
28. A comparison of three histological grading systems in endometrial cancer. Bilgin T, Ozuysal S, Ozan H. Arch Gynecol Obstet; 2005 Jun; 272(1):23-5. PubMed ID: 15241614 [Abstract] [Full Text] [Related]
29. [Prognostic value of histological variants of adenosquamous carcinoma of the corpus uteri]. Smirnov OA. Vopr Onkol; 1984 Jun; 30(3):32-7. PubMed ID: 6710946 [Abstract] [Full Text] [Related]
30. Architectural (FIGO) grading, nuclear grading, and other prognostic indicators in stage I endometrial adenocarcinoma with identification of high-risk and low-risk groups. Mittal KR, Schwartz PE, Barwick KW. Cancer; 1988 Feb 01; 61(3):538-45. PubMed ID: 3338021 [Abstract] [Full Text] [Related]
31. Adenocarcinoma of the endometrium. Twenty-five years' experience in private practice. Jones WE, Kanner HM, Kanner HH, Benson C. Trans Pac Coast Obstet Gynecol Soc; 1971 Feb 01; 39(0):128-36. PubMed ID: 5164805 [No Abstract] [Full Text] [Related]
32. [Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1]. Backe J, Gassel AM, Müller T, Schön S, Kaesemann H. Zentralbl Gynakol; 1997 Feb 01; 119(7):334-42. PubMed ID: 9340973 [Abstract] [Full Text] [Related]
33. [Therapeutic decisions. What is the value of radiotherapy in the treatment of adenocarcinoma of the endometrium?]. Leborgne F. Rev Interam Radiol; 1980 Jan 01; 5(1):31-4. PubMed ID: 6770449 [Abstract] [Full Text] [Related]
34. [Clinical studies of the radiosensitizing effect of small doses of ionizing radiation (preliminary data)]. Titova VA, Kalendo GS, Serebriakov NG. Med Radiol (Mosk); 1984 Nov 01; 29(11):52-5. PubMed ID: 6503648 [Abstract] [Full Text] [Related]
35. [Results of primary radiotherapy for corpus carcinoma in the years 1950-1966]. Hernuss P, Weghaupt K. Osterr Z Erforsch Bekampf Krebskr; 1972 Nov 01; 27(5):313-9. PubMed ID: 4678901 [No Abstract] [Full Text] [Related]
36. Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma. Demopoulos RI, Dubin N, Noumoff J, Blaustein A, Sommers GM. Obstet Gynecol; 1986 Aug 01; 68(2):245-50. PubMed ID: 3737041 [Abstract] [Full Text] [Related]
37. Staging and treatment of endometrial carcinoma. Welander C, Griem ML, Newton M, Marks JE. J Reprod Med; 1972 Jan 01; 8(1):41-6. PubMed ID: 5031003 [No Abstract] [Full Text] [Related]
38. Correlation between pretreatment prognostic factors and lymph node metastases in endometrial adenocarcinoma. Clinical application. La Fianza A, Alberici E, Generoso P, Preda L, Campani R. Radiol Med; 2000 Nov 01; 100(5):363-6. PubMed ID: 11213416 [Abstract] [Full Text] [Related]
39. Endometrial adenocarcinoma, adjuvant radiotherapy tailored to prognostic factors. Meerwaldt JH, Hoekstra CJ, van Putten WL, Tjokrowardojo AJ, Koper PC. Int J Radiat Oncol Biol Phys; 1990 Feb 01; 18(2):299-304. PubMed ID: 2303362 [Abstract] [Full Text] [Related]
40. Stage III Endometrial carcinoma: analysis of patterns of failure and therapeutic implications. Danoff BF, McDay J, Louka M, Lewis GC, Lee J, Kramer S. Int J Radiat Oncol Biol Phys; 1980 Nov 01; 6(11):1491-5. PubMed ID: 7462052 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]